April 2008 Editor's Picks: Leistritz and Millrock Technology - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

April 2008 Editor's Picks: Leistritz and Millrock Technology


Equipment and Processing Report

Untitled Document
Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Leistritz product Leistritz
Extruder processes small batches

The “Nano-16” twin-screw extruder from Leistritz (Somerville, NJ) incorporates a microplunger feeder that enables the unit to process 20–100-g batches. Charles Martin, general manager of Leistritz, explains that the microplunger feeder, a piston, uses positive displacement to feed small samples consistently at low rates. The extruder’s staging of unit operations and feeding are similar to those of a continuous process, Martin says. The machine runs continuously at rates ≤1000 g/h.

The device’s gearbox can drive 18- or 16-mm screws. Using a 16-mm screw produces an OD/ID ratio of 1.18 and a free volume of 0.9 cm3/diameter. The low free volume decreases the material’s residence time at low rates in the instrument, says Martin.

Unlike many small-volume extruders, the Nano-16 machine produces results that are scalable to production levels. The unit matches the shear rates of typical production-scale extruders, Martin says.


Millrock productMillrock Technology
Freeze dryer is hydrogen-peroxide sterilizable

Millrock Technology’s (Kingston, NY) “Max” series freeze dryers feature an option that enable them to be sterilized with hydrogen peroxide. T.N. Thompson, president of Millrock, says that this validatable sterilization method is more cost effective than steam sterilization because it requires no additional equipment. In addition, hydrogen-peroxide sterilization achieves “the same log reduction in biological activity” as steam sterilization, says Thompson.

Unlike comparable products, the Max series freeze dryers feature programmable logic control. Thompson notes that many machines this size incorporate microprocessor control instead, which is more limited. The machines can be provided with 21 CFR Part 11 software to meet regulatory requirements.

The freeze dryers have about 20 ft2 of shelf area and a maximum condensing capacity of 30 L. Biotechnology firms can perform sterile production runs with the Max series units, Thompson says.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
14%
To select process for new products only
23%
To select processes for both new and legacy products
20%
Do not use QbD
25%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Equipment and Processing Report,
Click here